Health Canada approved Wegovy (the obesity-specific formulation) in November 2021
These are likely long-term or permanent therapies for most people, not short courses
Medication consistency: Following the providers instructions may support treatment consistency
Key takeaways MeAgain is the GLP-1 progress tracker app where progress means more than weight: trend, photos, Journey Cards, dose context, food, side effects, protein, water, and medication-level context all sit on one timeline
Arillotta D, Floresta G, Papanti G, Guirguis A, Corkery JM, Martinotti G, et al
We are very excited to share that we have also submitted an FDA application to begin implementing the new tool to a wider population, and we are in the process of writing a publication to summarize the findings from baseline visits